VEGFA and neoplasm: Bevacizumab, an anti-VEGF antibody, prevents the growth of new blood vessels in the tumor tissue, increases vascular permeability facilitating the delivery of chemotherapeutic drugs, and promotes apoptosis of tumor cells [35].